23:30 , Aug 2, 2019 |  BC Extra  |  Financial News

Aug. 2 Financial Quick Takes: Rakuten Medical bags another $100M; plus CGeneTech, Zecen, Qyuns and more

Rakuten Medical raises another $100 million  Rakuten Medical Inc. (San Diego, Calif.) raised $100 million in a series C-1 round from existing investor Rakuten Inc. (Tokyo:4755), giving the Japanese internet giant a 22.6% stake. The...
18:25 , Aug 31, 2018 |  BC Week In Review  |  Financial News

Rakuten’s Mikitani leads Aspyrian's $150M series C

Rakuten Aspyrian Inc. (San Diego, Calif.) raised $150 million on Aug. 23 in a series C round led by Chairman Hiroshi Mikitani, who is CEO of Japanese e-commerce company Rakuten Inc. (Tokyo:4755). The round included...
15:32 , Aug 23, 2018 |  BC Extra  |  Financial News

Rakuten’s Mikitani leads Aspyrian's $150M series C

Rakuten Aspyrian Inc. (San Diego, Calif.) raised $150 million in a series C round led by Chairman Hiroshi Mikitani, who is CEO of Japanese e-commerce company Rakuten Inc. (Tokyo:4755). The round included other undisclosed private...
07:00 , Oct 13, 2016 |  BC Innovations  |  Translation in Brief

Zapping Tregs

A team at NIH's National Cancer Institute (NCI) has developed a phototherapy that selectively ablates Tregs in tumors to avoid the autoimmune liabilities of systemic immunotherapies. Despite their impressive efficacy, checkpoint inhibitors marketed to treat...
07:00 , Sep 1, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Interleukin-2 receptor α chain (CD25)

Cancer INDICATION: Cancer Mouse studies suggest a conjugate of an anti- CD25 mAb and a near-infrared (NIR) light-sensitive dye could help treat cancer. In cultures of a CD25-expressing mouse T cell line exposed to NIR,...
07:00 , Mar 14, 2016 |  BC Week In Review  |  Financial News

Aspyrian Therapeutics completes venture financing

Aspyrian Therapeutics Inc. , San Diego, Calif.   Business: Cancer, Antibodies   Date completed: 2016-03-10   Type: Venture financing   Raised: $40 million   Investor: Private investor  ...
03:21 , Mar 11, 2016 |  BC Extra  |  Financial News

Aspyrian raises $40M in series B round

Aspyrian Therapeutics Inc. (San Diego, Calif.) raised $40 million in a series B round from Hiroshi Mikitani, an Aspyrian director. Mikitani is CEO of Japanese e-commerce company Rakuten Inc. (Tokyo:4755). Aspyrian has an exclusive license...
07:00 , Aug 3, 2015 |  BC Week In Review  |  Financial News

Aspyrian Therapeutics financial update

Aspyrian Therapeutics Inc. , San Diego, Calif.   Business: Cancer, Antibodies   Date announced: 2015-07-27   Note: Aspyrian raised $4.3 million in an extension of a series A round, bringing the total raised in the...
01:09 , May 5, 2015 |  BC Extra  |  Company News

Management tracks

Metabolic play Intarcia Therapeutics Inc. (Boston, Mass.) named Michael Williams COO. Williams was head of global marketing at the Tokyo division of Takeda Pharmaceutical Co. Ltd. (Tokyo:4502). Neurology play Impax Laboratories Inc. (NASDAQ:IPXL) named Deborah...
08:00 , Feb 2, 2015 |  BC Week In Review  |  Financial News

Aspyrian Therapeutics completes venture financing

Aspyrian Therapeutics Inc. , San Diego, Calif.   Business: Cancer, Antibodies   Date completed: 2015-01-23   Type: Venture financing   Raised: $8.5 million   Investor: Not disclosed   Note: The company raised $8.5 million, according...